X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2021/09/02/2290770/29848/en/Flexion-Therapeutics-Announces-Inclusion-of-ZILRETTA-in-American-Academy-of-Orthopaedic-Surgeons-AAOS-Clinical-Practice-Guidelines-for-the-Management-of-Osteoarthritis-of-the-Knee.html
https://www.globenewswire.com/news-release/2021/06/09/2244381/0/en/Medexus-Announces-Availability-of-Triamcinolone-Hexacetonide-in-the-United-States.html#:~:text=TORONTO%20and%20CHICAGO%20and%20MONTREAL,)%20(TH)%20in%20the%20United
https://www.globenewswire.com/news-release/2020/07/09/2059954/0/en/Medexus-Reports-Triamcinolone-Hexacetonide-Injectable-Suspension-Approved-for-Inclusion-on-Federal-Provincial-Territorial-Public-Drug-Plan-Formularies.html
https://www.raps.org/news-and-articles/news-articles/2020/3/fda-requires-boxed-warning-for-singulair-generics
https://endpts.com/fda-requires-boxed-warning-for-singulair-and-its-generics/
https://www.globenewswire.com/news-release/2019/12/26/1964571/0/en/Flexion-Therapeutics-Announces-FDA-Approval-of-sNDA-to-Revise-ZILRETTA-triamcinolone-acetonide-extended-release-injectable-suspension-Product-Label.html
https://www.biospace.com/article/releases/flexion-therapeutics-enrolls-first-patients-in-phase-2-trial-of-zilretta-triamcinolone-acetonide-extended-release-injectable-suspension-in-oa-of-the-shoulder-and-adhesive-capsulitis/?s=68
https://www.fiercepharma.com/pharma/xofluza-hand-roche-offloads-tamiflu-u-s-otc-switch-rights-to-sanofi
https://www.pharmacompass.com/pdf/news/imprimis-njof-llc-receives-fda-warning-letter-1562735073.pdf
https://endpts.com/clearside-bio-loses-nearly-half-its-value-pre-market-as-lead-eye-drug-fails-pivotal-test/
https://www.fiercebiotech.com/biotech/clearside-slides-as-eye-drug-xipere-flunks-combination-study
https://www.fiercepharma.com/marketing/despite-initial-hurdles-flexion-ceo-says-new-pain-drug-zilretta-can-win-over
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207217
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.biospectrumasia.com/biospectrum/news/224125/glenmark-receives-anda-approval-nystatin-triamcinolone-acetonide-ointment
Market Place
Share 
